Amyris
Mr. John G. Melo (Pres, CEO & Director)
Mr. Hermanus Kieftenbeld (CFO & Chief Admin. Officer)
Mr. Eduardo Alvarez (Chief Operating Officer)
Summary
History
Amyris was founded in 2003. The company owns three brands, Biossance and Pipette, for beauty and skincare, and Purecane, a sugar substitute. The company went public on NASDAQ on September 28, 2010 .In November 2011, Amyris acquired Lansing, Michigan-based renewable chemicals and products company, Draths Corporation, for $7 million in stock. April 2019, the company raised $34-million in private placement of its common stock and warrants. The funding round was led by Foris Ventures and Dr. Wei-wu He, General Partner of Emerging Technology Partners, LLC, a life sciences-focused venture fund.In 2020, Amyris received Bonsucro's Chain of Custody Certification, ensuring that the sustainability claims along the sugarcane supply chain are traceable from farmer to end user. During the COVID-19 pandemic, the company collaborated with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine.
Mission
Vision
Key Team
Ms. Nicole Kelsey (Chief Legal Officer & Sec.)
Ms. Elizabeth E. Dreyer CPA (Chief Accounting Officer & Corp. Controller)
Mr. Peter DeNardo (Sr. Director of Investor Relations & Corp. Communications)
Ms. Christine Ofori (Chief People Officer)
Mr. Charles Kraft (Sr. VP of Global Manufacturing & Process Devel.)
Ms. Caroline Hadfield (Pres of Aprinnova)
Mr. Jim Iacoponi (Sr. VP of Nutrition Ingredients)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Mr. John G. Melo (Pres, CEO & Director)
Mr. Hermanus Kieftenbeld (CFO & Chief Admin. Officer)
Mr. Eduardo Alvarez (Chief Operating Officer)